NGNE
#2677
Neurogene Inc. - Common Stock
36.5 8 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.38%
Monthly Change
+8.71%
6 month change
+55.99%
Year Change
+24.34%
Previous Close
37.8 6
Open
36.5 8
Low
36.5 8
High
36.5 8
Volume
32
Financials
- Market Capitalization 732.02 M
- Employee 131
- Founded 2018
- CEO Jonathan Drachman M.D.
- Website www.neurogene.com
- Headquarter New York, United States
- FIGI BBG005Y0QDK1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.86
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2667 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.18 USD | +2.68% | +3.38% | +3.15% | -23.37% | 742.67 M USD | ||
| 2674 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.59 USD | -1.35% | -4.35% | +15.21% | -20.22% | 734.85 M USD | ||
| 2697 |  STTK Shattuck Labs, Inc. - Common Stock | 7.04 USD | -7.97% | -8.09% | +2.77% | +611.11% | 706.56 M USD | ||
| 2703 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.74 USD | -4.79% | -0.91% | +5.68% | -3.10% | 700.72 M USD |
Frequently asked questions about Neurogene, Inc. Common Stock
What is the Neurogene, Inc. Common Stock stock price today?
The current price of Neurogene, Inc. Common Stock (NGNE) is 36.58. Over the past 24 hours, the stock has changed by -3.38%. Follow the NGNE chart for real-time price dynamics.
What is the stock ticker of Neurogene, Inc. Common Stock?
Neurogene, Inc. Common Stock trades under the ticker NGNE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Neurogene, Inc. Common Stock stock going up?
NGNE has changed by -5.33% over the last week, +8.71% over the last month, and +24.34% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Neurogene, Inc. Common Stock?
Neurogene, Inc. Common Stock currently has a market capitalization of 732.02 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Neurogene, Inc. Common Stock earnings last quarter?
Last quarter, Neurogene, Inc. Common Stock reported earnings of -1.53 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Neurogene, Inc. Common Stock revenue for the last quarter?
Neurogene, Inc. Common Stock reported quarterly revenue of 100 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Neurogene, Inc. Common Stock net income for the last quarter?
Neurogene, Inc. Common Stock reported net income of -34.49 M for the last quarter. The previous quarter showed -30.93 M, which means net income changed by -11.49%.
How many employees does Neurogene, Inc. Common Stock have?
As of the latest available data, Neurogene, Inc. Common Stock has 131 employees. Workforce size can provide additional context about the company's scale and operations.
What is Neurogene, Inc. Common Stock EBITDA?
Neurogene, Inc. Common Stock EBITDA is -35.76 M, and its EBITDA margin is -35.76 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Neurogene, Inc. Common Stock stock?
You can buy Neurogene, Inc. Common Stock (NGNE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Neurogene, Inc. Common Stock stock?
Investing in Neurogene, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NGNE chart and related analysis on metatrader.com as part of your research.